ViaVerus serves MedTech and life science companies entering new markets and launching disruptive tech wanting to meet plan and achieve market scale.Disruptive products demand higher margins and allow companies to compete differently. A sales team armed with a disruptive product and a repeatable sale process TAKE market share.ViaVerus utilizes the Agile Market Entry (AME) sales framework with products now owned by companies like IQVIA and Johnson and Johnson. AME works for the startup and the market leader.Conventional sales strategies, even modern ones like solution selling or the challenger sale, are designed for established products.With new markets or disruptive tech, conventional methods impede and often prevent market success resulting in premature scaling (unnecessary burn and wasted budgets) and the inability to achieve scale.Entering new markets and launching disruptive tech requires a shift in approach. New thinking. Different operating principles. When executing AME, teams experience:• Meeting their revenue targets while eliminating premature scaling (wasted burn).• Growing all product lines. Getting into previously inaccessible competitive accounts.• Building a team to do it over and over -- adding new skills and capability to your organization. • Customers that love you and the company. Solving very real customer problems maybe for the 1st time.MY STORYAfter 25+ years leading product launches, I started to look for a sales model that reflected the empirical data I had witnessed over decades. I just found pieces. Like Clay Christensen’s JTBD, Steve Blank’s customer discovery and The Lean Startup. And I knew conventional sales models didn’t work for disruptive tech; they actually impeded, and often prevented, success.What started as a search became the spark of a new idea - my AME sales framework. After 15+ years using AME with clients, I am now writing a business novel, The Launch. Contact me to join the ‘early readers’ list.WHAT CLIENTS SAYDue to Chris’ efforts EA became a recognized market leader despite being a much smaller company than its key competitors.Don Holzworth, CEO of Expression Analysis (now IQVIA)Chris can quickly and accurately assess the market and customer dynamics and provide actionable advice. Chris makes a real impact and does it with the highest integrity.Brian Regan, VP of Marketing, TearScience (now JNJ)If you’re interested in how ViaVerus can help your team with their next product launch, send me a message.